IlluminOss Medical
Medical Equipment Manufacturing • 
East Providence, Rhode Island, United States • 21-50 Employees
Company overview
| Headquarters | 993 Waterman Avenue, East Providence, RI 02914, US |
| Phone number | +14017140008 |
| Website | |
| NAICS | 3391 |
| SIC | 384 |
| Keywords | Orthopaedics, Trauma, Augmentation, Distal Radius, Fibula, Humerus, Pelvic Fragility Fracture, Clavicle, Distal Femur With A Plate, Fracture Repair, Fragility Fractures, Geriatric Fracture, Metacarpal, Metatarsal, Minimally Invasive Fracture Repair, Poor Bone Quality, Proximal Humerus, Ulna, Rapid Return To Function |
| Founded | 2007 |
| Employees | 21-50 |
| Socials |
Key Contacts at IlluminOss Medical
Craig Decker
Chief Executive Officer
Beth Money
Director Of Operations
Liane Fuest
Global Director Marketing And Sales Operations
IlluminOss Medical Email Formats
IlluminOss Medical uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@illuminoss.com), used 55% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@illuminoss.com | 55% |
{first name}{last name} | johndoe@illuminoss.com | 45% |
About IlluminOss Medical
IlluminOss Medical is a privately-held, commercial stage medical device company focused on designing, developing and marketing orthopedic fracture repair products that leverage its proprietary bone stabilization technology, the IlluminOss System. This minimally invasive technology allows for fracture stabilization through the use of patient specific intramedullary implants. IlluminOss utilizes a light-curable polymer, contained within an expandable balloon catheter, to achieve bone stabilization. The revolutionary procedure is made through a small percutaneous surgical approach providing patients and clinicians with a fast, patient-specific, method of fracture stabilization. US Indications: The IlluminOss System is indicated for use in skeletally mature patients in the treatment of traumatic, fragility, pathological, and impending pathological fractures of the humerus, radius, ulna, clavicle, pelvis, fibula, metacarpals, metatarsals, and phalanges. The IlluminOss System can also be used in conjunction with FDA-cleared fracture fixation systems to provide supplemental fixation in these anatomic sites. The IlluminOss System may be used in the femur and tibia to provide supplemental fixation to an anatomically appropriate FDA-cleared fracture fixation system. EU Indications: The IlluminOss System is indicated for use in fracture alignment reduction. It provides stabilization for bone fractures using a minimally invasive technique in which the bone is not subjected to significant weight bearing forces. This IlluminOss procedure pack is intended for use in treatment of the metacarpal, phalange, clavicle, radius, ulna, distal radius, olecranon and fibula. It is also indicated for the treatment of impending and actual pathological fractures of the humerus from metastatic bone disease. For more detailed procedural information including Warnings, Cautions, Risks & Contraindications, please visit www.illuminOss.com for the correct surgical technique guide.
IlluminOss Medical revenue & valuation
| Annual revenue | $8,800,000 |
| Revenue per employee | $259,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $28,200,000 |
| Total funding | $5,000,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
IlluminOss Medical has 16 employees across 8 departments.
Departments
Number of employees
IlluminOss Medical Tech Stack
Discover the technologies and tools that power IlluminOss Medical's digital infrastructure, from frameworks to analytics platforms.
Programming languages
JavaScript libraries
Programming languages
Analytics
UI frameworks
JavaScript libraries
Web frameworks
JavaScript frameworks
Web servers
Tag managers
Saudi Arabia
Canada
Germany
Frequently asked questions
4.8
40,000 users
